Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 18Terminated 4Withdrawn 2Unknown 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 50Carcinoma, Non-Small-Cell Lung 36Ovarian Neoplasms 35Stomach Neoplasms 32Esophageal Neoplasms 29Uterine Cervical Neoplasms 21Esophageal Squamous Cell Carcinoma 19Fallopian Tube Neoplasms 16Lung Neoplasms 13Carcinoma, Ovarian Epithelial 13Neoplasms 9Head and Neck Neoplasms 9Carcinoma, Squamous Cell 9Triple Negative Breast Neoplasms 8Recurrence 8Neoplasm Metastasis 6Endometrial Neoplasms 6Advanced Gastric Cancer 6Squamous Cell Carcinoma of Head and Neck 5Pancreatic Neoplasms 5Nasopharyngeal Neoplasms 5Hypopharyngeal Neoplasms 4Oropharyngeal Neoplasms 3Nasopharyngeal Carcinoma 3Mouth Neoplasms 3Melanoma 3Laryngeal Neoplasms 3Carcinoma 3Anus Neoplasms 3Adenocarcinoma Of Esophagus 3

Interventions

Gefitinib 3Neoadjuvant Therapy 2Gemcitabine 2Erlotinib Hydrochloride 2motesanib diphosphate 1Paclitaxel 1Cisplatin 1Chemotherapy, Adjuvant 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Adenocarcinoma, Bronchiolo-Alveolar × Paclitaxel × Clear all
NCT01024712 2013-08-12

Paclitaxel, Carboplatin, and Gefitinib in Treating Patients With Advanced Non-Small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
26 enrolled
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡